by Plus Therapeutics | Nov 6, 2024 | Uncategorized
BREAKING NEWS: Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda and reinforce supply chain redundancy Press...
by Plus Therapeutics | Oct 30, 2024 | Uncategorized
Come join us at the upcoming @the_abta 5K run in New York City! It’s not too late to register as we join together in the fight against brain cancer. Plus Therapeutics is proud to be a sponsor and will have a booth on-site to provide education about our clinical...
by Plus Therapeutics | Sep 30, 2024 | Uncategorized
Reminder to come by Plus Therapeutics at the @CNS_update 2024 Annual Meeting at Booth #2038 Plus Therapeutics is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the...
by Plus Therapeutics | Sep 24, 2024 | Uncategorized
Today is #WorldCancerResearchDay! Join us in celebrating the incredible advancements in cancer research and the dedicated researchers working tirelessly to find new treatments and cures. Every breakthrough brings us one step closer to a cancer-free future🔬🌟🎗️ Learn...
by Plus Therapeutics | Sep 23, 2024 | Uncategorized
Cheers to our amazing team members at Plus Therapeutics who are celebrating their work anniversaries this last quarter! Your hard work and dedication make all the difference. Here’s to many more achievements together! 🌟...
by Plus Therapeutics | Sep 20, 2024 | Uncategorized
Don’t forget to come by the Plus Therapeutics booth at these upcoming community events next week in Texas! Our patient advocacy team can’t wait to meet you. 🎗️🧠 https://give.headforthecure.org/event/head-for-the-cure-5k-san-antonio-2024/e544230...
Recent Comments